$-0.02 EPS Expected for PURE Bioscience, Inc. (PURE)
February 23, 2018 – By Vivian Park
Analysts expect PURE Bioscience, Inc. (OTCMKTS:PURE) to report $-0.02 EPS on March, 1.They anticipate $0.01 EPS change or 100.00 % from last quarter’s $-0.01 EPS. After having $-0.04 EPS previously, PURE Bioscience, Inc.’s analysts see -50.00 % EPS growth. It closed at $0.79 lastly. It is down 0.00% since February 23, 2017 and is . It has underperformed by 16.70% the S&P500.
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company has market cap of $53.67 million. It makes and distributes silver dihydrogen citrate , a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. It currently has negative earnings. The firm offers SDC disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILV??RION, an antimicrobial solution used against bacteria, viruses, yeast, and molds.
More notable recent PURE Bioscience, Inc. (OTCMKTS:PURE) news were published by: Businesswire.com which released: “PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen …” on November 02, 2017, also Forbes.com with their article: “Pure Bioscience Looks For Silver Lining” published on July 30, 2009, Seekingalpha.com published: “PURE Bioscience’s (PURE) CEO Hank Lambert on Q3 2017 Results - Earnings Call …” on June 09, 2017. More interesting news about PURE Bioscience, Inc. (OTCMKTS:PURE) were released by: Businesswire.com and their article: “PURE Bioscience to Present at 2017 SeeThru Equity Investor Conference” published on September 14, 2017 as well as Businesswire.com‘s news article titled: “PURE Bioscience Reports Fiscal 2018 Q1 Financial Results” with publication date: December 14, 2017.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.